Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

11 May 2018 15:38

RNS Number : 8690N
Synectics PLC
11 May 2018
 

 

11 May 2018

 

 

 

Synectics plc

(the 'Company')

Exercise of Options under Share Plan and subsequent Sale of Shares

PDMR shareholdings

 

Synectics (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, announces that on 9 May 2018 the following share options, which vested under the performance criteria of its Performance Share Plan ('PSP'), were exercised and either held or sold by Executive Directors and other Persons Discharging Managerial Responsibility ('PDMRs').

 

 

Number of shares

Name

Position

Status

PSP options exercised

Of which, subsequently held in own name

Of which, subsequently sold

Paul Webb*

Chief Executive, Synectics plc

Executive Director and PDMR

50,000

26,322

23,678

Mike Stilwell

Finance Director, Synectics plc

Executive Director and PDMR

25,000

-

25,000

David Aindow

Business Strategy Director, Synectic Systems Group Limited

PDMR

25,000

-

25,000

Darren Alder

Divisional Director, Oil & Gas, Synectic Systems Group Limited

PDMR

7,500

-

7,500

Stacey Anderson

Managing Director, SSS Management Services

PDMR

7,500

-

7,500

Jeff Fail

Organisational Development Director, Synectics plc

PDMR

30,000

-

30,000

 

*Paul Webb, Chief Executive, sold sufficient shares to cover the immediate tax liability on exercise of the options. The balance of 26,322 shares were transferred into his own name.

 

Following these transactions, their total interests in Synectics shares are now as follows:

 

Name

Position

Ordinary shares held

Interest in shares in share schemes

Resultanttotalinterest

% ofissuedshare capital

Paul Webb

Chief Executive, Synectics plc

36,322

251,325

287,647

1.62%

Mike Stilwell

Finance Director, Synectics plc

6,910

26,273

33,183

0.19%

David Aindow

Business Strategy Director, Synectic Systems Group Limited

-

13,000

13,000

0.07%

Darren Alder

Divisional Director, Oil & Gas, Synectic Systems Group Limited

-

15,000

15,000

0.08%

Stacey Anderson

Managing Director, SSS Management Services

-

16,000

16,000

0.09%

Jeff Fail

Organisational Development Director, Synectics plc

-

14,000

14,000

0.08%

 

 

 

Full details of the PSP are set out in the Company's Annual Report for the year ended 30 November 2017.

 

Commenting, Paul Webb, Chief Executive, said:

 

"I am very pleased that the Company's performance has led to the vesting in full of the share awards issued in March 2015.

 

"I have chosen to retain the maximum number of shares from my award after selling sufficient to cover the immediate tax liability. Other award holders have made their own individual choices."

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Jan Mitson, Deputy Company Secretary

www.synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths/Henry Willcocks

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEALSFFDKPEFF
Date   Source Headline
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company
9th Dec 20241:30 pmRNSHoldings in Company
9th Dec 20247:00 amRNSTrading Update
5th Dec 20247:00 amRNS$2.7 million Contract Awards
27th Nov 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.